TeleDaaS Launches as Premier Provider of Dosimetry as a Service for Clinical Research Organizations
Imaging Technology
NOVEMBER 26, 2023
TeleDaaS specializes in delivering clinical-grade, precision-based dosimetry analysis and treatment plans to clinical research organizations (CROs) and pharmaceutical manufacturers. TeleDaaS licenses a cloud-based technology platform from Mirada Medical. months from 10.7 on the standard dosimetry arm of the trial.
Let's personalize your content